Regular Aspirin Use To Prevent Cardiovascular Events Not Advisable For Most Patients – ACC/AHA Guidelines
Executive Summary
Aspirin should be used very selectively in the primary prevention of artherosclerotic cardiovascular disease, according to new guidelines from the American College of Cardiology and American Heart Association. While certain higher-risk adults may benefit from regular, preventative aspirin use, those over the age of 70, and any at increased risk of bleeding, should explore lifestyle changes, the groups say.
You may also be interested in...
Recommending Aspirin For CVD Prevention: Understanding Patients Superior To Guidelines – Commentary
Researchers from Florida Atlantic University, University of Wisconsin, Harvard and Brigham and Women’s Hospital suggest medical professionals understanding of their patients supersedes guidelines in making determinations about aspirin use as a primary prevention for cardiovascular events.
Breast Cancer Study Finds Benefit From Aspirin Use Linked To DNA Profiles
Breast cancer mortality among women who regularly used aspirin decreased 22%-40% for those with unmethylated tumor promoter and progesterone receptor genes, while women with methylated tumor promoter had of 67% all-cause death risk, study finds. Researchers and editorial author say study underscores importance of looking at methylation profiles, or chemical changes, in tumor tissue DNA.
‘Widespread’ Aspirin Use To Prevent CVD By Consumers At Risk Of Harm, NHIS Data Show
Aspirin use to prevent CVD "widespread" among US adults who should not use it regularly, according to analysis of 2017 National Health Interview Survey. Nearly half of adults 70 and up without self-reported CVD take aspirin even though guidelines recommend against routine use by persons that age and those with increased bleeding risk.